
Sign up to save your podcasts
Or


Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.
By Dr. Neil Love4.4
7272 ratings
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
CME information and select publications here.

319 Listeners

40 Listeners

68 Listeners

31 Listeners

14 Listeners

18 Listeners

12 Listeners

0 Listeners

120 Listeners

58 Listeners

1,150 Listeners

46 Listeners

2 Listeners

376 Listeners

53 Listeners

59 Listeners

51 Listeners

196 Listeners

48 Listeners

30 Listeners

0 Listeners